Cannara Biotech, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 6.36% vs 3.66% in Aug 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is -69.70% vs -19.51% in Aug 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Aug'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.10",
          "val2": "28.30",
          "chgp": "6.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-0.90",
          "chgp": "44.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.90",
          "chgp": "-22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.80",
          "val2": "8.00",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.00",
          "val2": "3.30",
          "chgp": "-69.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-69.80%",
          "val2": "-109.10%",
          "chgp": "3.93%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2025 is 31.21% vs 42.58% in Aug 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2025 is 104.69% vs -7.25% in Aug 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Aug'25",
        "Aug'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "107.20",
          "val2": "81.70",
          "chgp": "31.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.30",
          "val2": "-11.60",
          "chgp": "88.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.40",
          "val2": "5.70",
          "chgp": "-22.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "29.60",
          "val2": "25.60",
          "chgp": "15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.10",
          "val2": "6.40",
          "chgp": "104.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-74.30%",
          "val2": "-219.10%",
          "chgp": "14.48%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ

Nov'25

Aug'25

Change(%)

Net Sales

30.10

28.30

6.36%

Operating Profit (PBDIT) excl Other Income

-0.50

-0.90

44.44%

Interest

0.70

0.90

-22.22%

Exceptional Items

4.80

8.00

-40.00%

Consolidate Net Profit

1.00

3.30

-69.70%

Operating Profit Margin (Excl OI)

-69.80%

-109.10%

3.93%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Nov 2025 is 6.36% vs 3.66% in Aug 2025

Consolidated Net Profit

QoQ Growth in quarter ended Nov 2025 is -69.70% vs -19.51% in Aug 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Aug'25

Aug'25

Aug'24

Change(%)

Net Sales

107.20

81.70

31.21%

Operating Profit (PBDIT) excl Other Income

-1.30

-11.60

88.79%

Interest

4.40

5.70

-22.81%

Exceptional Items

29.60

25.60

15.62%

Consolidate Net Profit

13.10

6.40

104.69%

Operating Profit Margin (Excl OI)

-74.30%

-219.10%

14.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Aug 2025 is 31.21% vs 42.58% in Aug 2024

Consolidated Net Profit

YoY Growth in year ended Aug 2025 is 104.69% vs -7.25% in Aug 2024

All Annual Results